GlassScriptPhysician profile
Amal Benchakroun
NPI 1114504420
$493.64
in general payments reported to CMS, 2019-2025
9 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $17.31 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $136.91 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.43 | 2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $80.96 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| United Therapeutics Corporation | $58.95 | 2025 | Tyvaso |
| Abiomed | $35.34 | 2025 | |
| Edwards Lifesciences Corporation | $26.84 | 2025 | |
| Merck Sharp & Dohme LLC | $25.52 | 2025 | Winrevair |
| Scpharmaceuticals INC. | $19.00 | 2025 | |
| Genzyme Corporation | $16.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amal Benchakroun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.